179 related articles for article (PubMed ID: 28916546)
1. Approach to Membranous Lupus Nephritis: A Survey of Pediatric Nephrologists and Pediatric Rheumatologists.
Boneparth A; Radhakrishna SM; Greenbaum LA; Yen E; Okamura DM; Cooper JC; Mason S; Levy DM; Sule SD; Jensen PT; Yildirim-Toruner C; Ardoin SP; Wenderfer SE
J Rheumatol; 2017 Nov; 44(11):1619-1623. PubMed ID: 28916546
[TBL] [Abstract][Full Text] [Related]
2. Differences in rituximab use between pediatric rheumatologists and nephrologists for the treatment of refractory lupus nephritis and renal flare in childhood-onset SLE.
Gilbert M; Goilav B; Hsu JJ; Nietert PJ; Meidan E; Chua A; Ardoin SP; Wenderfer SE; von Scheven E; Ruth NM;
Pediatr Rheumatol Online J; 2021 Aug; 19(1):137. PubMed ID: 34461932
[TBL] [Abstract][Full Text] [Related]
3. Practice patterns and approach to kidney biopsy in lupus: a collaboration of the Midwest Pediatric Nephrology Consortium and the Childhood Arthritis and Rheumatology Research Alliance.
Wenderfer SE; Lane JC; Shatat IF; von Scheven E; Ruth NM
Pediatr Rheumatol Online J; 2015 Jun; 13():26. PubMed ID: 26087651
[TBL] [Abstract][Full Text] [Related]
4. [Proliferative lupus nephritis treatment: practice survey in nephrology and internal medicine in France].
Jourde-Chiche N; Chiche L; Mancini J; Daniel L; Bardin N; Burtey S; Gondouin B; Dussol B; Harlé JR; Hamidou M; Meulders Q; Daugas E;
Nephrol Ther; 2014 Jun; 10(3):170-6. PubMed ID: 24703567
[TBL] [Abstract][Full Text] [Related]
5. Use of EuroLupus Cyclophosphamide Dosing for the Treatment of Lupus Nephritis in Childhood-onset Systemic Lupus Erythematosus in North America.
Cannon LA; Wenderfer SE; Lewandowski LB; Cooper JC; Goilav B; Knight AM; Hersh AO; Ardoin SP; Sadun RE;
J Rheumatol; 2022 Jun; 49(6):607-614. PubMed ID: 35169053
[TBL] [Abstract][Full Text] [Related]
6. Clinical presentation and outcomes of childhood-onset membranous lupus nephritis.
Pereira M; Muscal E; Eldin K; Hicks MJ; Sagcal-Gironella ACP; DeGuzman M; Wenderfer SE
Pediatr Nephrol; 2017 Dec; 32(12):2283-2291. PubMed ID: 28717937
[TBL] [Abstract][Full Text] [Related]
7. Clinical characteristics of children with membranous lupus nephritis: the Childhood Arthritis and Rheumatology Research Alliance Legacy Registry.
Boneparth A; Wenderfer SE; Moorthy LN; Radhakrishna SM; Sagcal-Gironella AC; von Scheven E;
Lupus; 2017 Mar; 26(3):299-306. PubMed ID: 27510603
[TBL] [Abstract][Full Text] [Related]
8. Refractory lupus nephritis: a survey.
Weidenbusch M; Bai Y; Eder J; Anders HJ;
Lupus; 2019 Apr; 28(4):455-464. PubMed ID: 30755142
[TBL] [Abstract][Full Text] [Related]
9. Mycophenolate mofetil as the primary treatment of membranous lupus nephritis with and without concurrent proliferative disease: a retrospective study of 29 cases.
Kasitanon N; Petri M; Haas M; Magder LS; Fine DM
Lupus; 2008 Jan; 17(1):40-5. PubMed ID: 18089682
[TBL] [Abstract][Full Text] [Related]
10. Research priorities in childhood-onset lupus: results of a multidisciplinary prioritization exercise.
Ardoin SP; Daly RP; Merzoug L; Tse K; Ardalan K; Arkin L; Knight A; Rubinstein T; Ruth N; Wenderfer SE; Hersh AO;
Pediatr Rheumatol Online J; 2019 Jul; 17(1):32. PubMed ID: 31262324
[TBL] [Abstract][Full Text] [Related]
11. Immunosuppressive treatment for pure membranous lupus nephropathy in a Hispanic population.
Mejía-Vilet JM; Córdova-Sánchez BM; Uribe-Uribe NO; Correa-Rotter R
Clin Rheumatol; 2016 Sep; 35(9):2219-27. PubMed ID: 27475791
[TBL] [Abstract][Full Text] [Related]
12. [Interdisciplinary consensus to management of lupus nephritis in Germany].
de Groot K
Z Rheumatol; 2007 Dec; 66(8):724, 726. PubMed ID: 17965864
[TBL] [Abstract][Full Text] [Related]
13. Hydroxychloroquine use predicts complete renal remission within 12 months among patients treated with mycophenolate mofetil therapy for membranous lupus nephritis.
Kasitanon N; Fine DM; Haas M; Magder LS; Petri M
Lupus; 2006; 15(6):366-70. PubMed ID: 16830883
[TBL] [Abstract][Full Text] [Related]
14. Overview of lupus nephritis management guidelines and perspective from Asia.
Mok CC; Yap DY; Navarra SV; Liu ZH; Zhao MH; Lu L; Takeuchi T; Avihingsanon Y; Yu XQ; Lapid EA; Lugue-Lizardo LR; Sumethkul V; Shen N; Chen SL; Chan TM;
Int J Rheum Dis; 2013 Dec; 16(6):625-36. PubMed ID: 24382275
[TBL] [Abstract][Full Text] [Related]
15. Pilot 24 month study to compare mycophenolate mofetil and tacrolimus in the treatment of membranous lupus nephritis with nephrotic syndrome.
Yap DY; Yu X; Chen XM; Lu F; Chen N; Li XW; Tang CS; Chan TM
Nephrology (Carlton); 2012 May; 17(4):352-7. PubMed ID: 22295934
[TBL] [Abstract][Full Text] [Related]
16. Practice Variations in the Diagnosis, Monitoring, and Treatment of Systemic Lupus Erythematosus in Canada.
Keeling SO; Bissonauth A; Bernatsky S; Vandermeer B; Fortin PR; Gladman DD; Peschken C; Urowitz MB
J Rheumatol; 2018 Oct; 45(10):1440-1447. PubMed ID: 30068762
[TBL] [Abstract][Full Text] [Related]
17. [Interest of mycophenolate mofetil in children with membranous lupus nephritis].
Gargah T; Goucha-Louzir R; Lakhoua MR
Nephrol Ther; 2010 Dec; 6(7):564-8. PubMed ID: 20829140
[TBL] [Abstract][Full Text] [Related]
18. [Mycophenolate mofetil in treatment of childhood nephrotic syndrome--preliminary report].
Kwinta-Rybicka J; Wilkosz K; Wierzchowska-Słowiacze EK; Ogarek I; Moczulska A; Stec Z; Pełkowska A; Sancewicz-Pach K; Pietrzyk JA
Przegl Lek; 2006; 63 Suppl 3():44-8. PubMed ID: 16898486
[TBL] [Abstract][Full Text] [Related]
19. Mycophenolate mofetil therapy for children with lupus nephritis refractory to both intravenous cyclosphosphamide and cyclosporine.
Fu YF; Liu GL
Clin Nephrol; 2001 Apr; 55(4):318-21. PubMed ID: 11334319
[TBL] [Abstract][Full Text] [Related]
20. Mycophenolate mofetil as maintenance therapy for childhood-onset systemic lupus erythematosus patients with severe lupus nephritis.
Kizawa T; Nozawa T; Kikuchi M; Nagahama K; Okudela K; Miyamae T; Imagawa T; Nakamura T; Mori M; Yokota S; Tsutsumi H
Mod Rheumatol; 2015 Mar; 25(2):210-4. PubMed ID: 25159157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
